Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

This study has been completed.
Sponsor:
Information provided by:
Cell Genesys
ClinicalTrials.gov Identifier:
NCT00116467
First received: June 29, 2005
Last updated: December 18, 2007
Last verified: December 2007